Literature DB >> 21232818

Genetic prion disease with codon 196 PRNP mutation: clinical and pathological findings.

Gabi Schelzke1, Sabina Eigenbrod, Carlos Romero, Daniela Varges, Maren Breithaupt, Ana L Taratuto, Hans A Kretzschmar, Inga Zerr.   

Abstract

Ten percent to 15% of all human transmissible spongiform encephalopathy are characterized by a mutation in prion protein gene (PRNP). They are distinct with respect to clinical signs, disease onset, disease duration, and diagnostic findings. During our surveillance activities in Germany, we identified 7 patients with the rare mutation E196K in PRNP gene, thereof 4 patients belonging to 2 families. The clinical syndromes were characterized by nonspecific and psychiatric symptoms at disease onset and progressed to predominant motor signs. These patients showed a late median disease onset of 71 years and short disease duration of 6.5 months. In absence of family history, they mimicked sporadic Creutzfeldt-Jakob disease (CJD). In clinical tests they were 100% positive for 14-3-3 protein detection in cerebrospinal fluid and less sensitive for magnetic resonance imaging (MRI) and electroencephalogram (EEG) abnormalities. As a secondary magnetic resonance imaging (MRI) abnormality, we have seen conspicuous common involvement of the subcortical white matter in 57%. Four patients underwent autopsy-pathological lesions revealed striking similarity to sporadic Creutzfeldt-Jakob disease but also involvement of the white matter.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21232818     DOI: 10.1016/j.neurobiolaging.2010.11.023

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  7 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

Review 2.  14-3-3 proteins as potential therapeutic targets.

Authors:  Jing Zhao; Cheryl L Meyerkord; Yuhong Du; Fadlo R Khuri; Haian Fu
Journal:  Semin Cell Dev Biol       Date:  2011-10-01       Impact factor: 7.727

3.  A Chinese Creutzfeldt-Jakob disease patient with E196K mutation in PRNP.

Authors:  Qi Shi; Cao Chen; Xiao-Nan Song; Chen Gao; Chan Tian; Wei Zhou; Xu-Hua Song; Lai-Shun Yao; Jun Han; Xiao-Ping Dong
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

4.  Rare E196A mutation in PRNP gene of 3 Chinese patients with Creutzfeldt-Jacob disease.

Authors:  Qi Shi; Wei Zhou; Cao Chen; Bao-Yun Zhang; Kang Xiao; Yuan Wang; Xiao-Ping Dong
Journal:  Prion       Date:  2016-07-03       Impact factor: 3.931

5.  Genetic prion disease-related mutation E196K displays a novel amyloid fibril structure revealed by cryo-EM.

Authors:  Li-Qiang Wang; Kun Zhao; Han-Ye Yuan; Xiang-Ning Li; Hai-Bin Dang; Yeyang Ma; Qiang Wang; Chen Wang; Yunpeng Sun; Jie Chen; Dan Li; Delin Zhang; Ping Yin; Cong Liu; Yi Liang
Journal:  Sci Adv       Date:  2021-09-08       Impact factor: 14.136

6.  Characteristics of Chinese patients with genetic CJD who have E196A or E196K mutation in PRNP: comparative analysis of patients identified in the Chinese National CJD Surveillance System.

Authors:  Qi Shi; Kang Xiao; Cao Chen; Wei Zhou; Li-Ping Gao; Yue-Zhang Wu; Yuan Wang; Chao Hu; Chen Gao; Xiao-Ping Dong
Journal:  BMJ Open       Date:  2021-11-15       Impact factor: 2.692

Review 7.  Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases.

Authors:  Eva Bagyinszky; Vo Van Giau; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-14       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.